Log in

Acerus Pharmaceuticals Stock Price, News & Analysis (TSE:ASP)

C$0.09
0.00 (0.00 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
C$0.08
Now: C$0.09
C$0.09
50-Day Range
C$0.08
MA: C$0.11
C$0.14
52-Week Range
C$0.07
Now: C$0.09
C$0.24
Volume58,000 shs
Average Volume105,290 shs
Market CapitalizationC$23.51 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone416-679-0771

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$7.07 million
Cash FlowC$0.01 per share
Book ValueC($0.02) per share

Profitability

Miscellaneous

Employees29
Market CapC$23.51 million
Next Earnings Date11/4/2019 (Estimated)
OptionableNot Optionable

Receive ASP News and Ratings via Email

Sign-up to receive the latest news and ratings for ASP and its competitors with MarketBeat's FREE daily newsletter.


Acerus Pharmaceuticals (TSE:ASP) Frequently Asked Questions

What is Acerus Pharmaceuticals' stock symbol?

Acerus Pharmaceuticals trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ASP."

How were Acerus Pharmaceuticals' earnings last quarter?

Acerus Pharmaceuticals Co. (TSE:ASP) released its earnings results on Tuesday, August, 6th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company earned $1.68 million during the quarter, compared to analysts' expectations of $3.70 million. View Acerus Pharmaceuticals' Earnings History.

When is Acerus Pharmaceuticals' next earnings date?

Acerus Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Acerus Pharmaceuticals.

Has Acerus Pharmaceuticals been receiving favorable news coverage?

News articles about ASP stock have trended somewhat negative this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Acerus Pharmaceuticals earned a media sentiment score of -1.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Acerus Pharmaceuticals.

Who are some of Acerus Pharmaceuticals' key competitors?

What other stocks do shareholders of Acerus Pharmaceuticals own?

Who are Acerus Pharmaceuticals' key executives?

Acerus Pharmaceuticals' management team includes the folowing people:
  • Dr. Nathan Bryson, Chief Scientific Officer
  • Mr. Philippe Savard, VP, Gen. Counsel & Corp. Sec.
  • Mr. Edward Gudaitis, Pres , CEO & Director
  • Mr. Robert M. Motz, Chief Financial Officer
  • Mr. Hubert Tomasz Czerwinski, Pres of Acerus Pharmaceuticals SRL

How do I buy shares of Acerus Pharmaceuticals?

Shares of ASP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Acerus Pharmaceuticals' stock price today?

One share of ASP stock can currently be purchased for approximately C$0.09.

How big of a company is Acerus Pharmaceuticals?

Acerus Pharmaceuticals has a market capitalization of C$23.51 million and generates C$7.07 million in revenue each year. Acerus Pharmaceuticals employs 29 workers across the globe.View Additional Information About Acerus Pharmaceuticals.

What is Acerus Pharmaceuticals' official website?

The official website for Acerus Pharmaceuticals is http://www.aceruspharma.com/.

How can I contact Acerus Pharmaceuticals?

The company can be reached via phone at 416-679-0771.


MarketBeat Community Rating for Acerus Pharmaceuticals (TSE ASP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  115 (Vote Underperform)
Total Votes:  227
MarketBeat's community ratings are surveys of what our community members think about Acerus Pharmaceuticals and other stocks. Vote "Outperform" if you believe ASP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ASP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: What is intrinsic value?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel